Senseonics Holdings (SENS) Financials: History & Chart

Senseonics Holdings, Inc.(SENS)

Medical - Devices · Germantown, MD

$9.96-0.35 (-3.39%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Senseonics Holdings, Inc.

Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.

Germantown, MD

130 employees

www.senseonics.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Timothy T. Goodnow

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	48.55M	14.48M	11.71M	14.26M	8.10M	6.65M	6.26M	8.30M	4.26M
Cost of Goods Sold	21.91M	5.92M	4.77M	6.59M	4.63M	3.53M	4.75M	4.35M	8.31M
Gross Profit	26.64M	8.56M	6.94M	7.67M	3.47M	3.12M	1.50M	3.95M	-4.05M
Gross Profit Margin	54.9%	59.1%	59.3%	53.8%	42.8%	46.9%	24.1%	47.6%	-95.0%
Total Operating Expenses	135.00M	44.55M	38.79M	28.59M	23.07M	17.44M	14.99M	18.22M	18.80M
Research & Development	36.83M	11.64M	8.61M	8.82M	7.76M	7.71M	7.30M	9.36M	10.55M
Selling, General & Administrative	98.17M	32.91M	30.18M	19.77M	15.31M	9.73M	7.69M	8.86M	8.25M
Operating Income (EBIT)	-108.36M	-35.99M	-31.85M	-20.93M	-19.60M	-14.32M	-13.49M	-14.27M	-22.85M
Operating Margin	-223.2%	-248.5%	-271.9%	-146.8%	-242.1%	-215.4%	-215.6%	-172.0%	-535.9%
Income Before Tax (EBT)	-109.39M	-36.70M	-32.33M	-20.82M	-19.53M	-14.50M	-14.26M	-15.48M	-23.98M
Interest Income	4.32M	1.03M	742K	1.31M	1.24M	973K	675K	918K	1.01M
Interest Expense	5.17M	1.60M	1.19M	1.21M	1.17M	1.15M	1.43M	2.17M	2.13M
Other Income/Expense	-1.03M	-717K	-487K	102K	71K	-178K	-771K	-1.21M	-1.13M
Net Income	-109.39M	-36.70M	-32.33M	-20.82M	-19.53M	-14.50M	-14.26M	-15.48M	-23.98M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-225.3%	-253.4%	-276.1%	-146.1%	-241.3%	-218.1%	-227.9%	-186.5%	-562.4%
EBITDA	-106.51M	-35.44M	-31.30M	-20.54M	-19.23M	-13.95M	-13.10M	-13.51M	-22.65M
EBITDA Margin	-219.4%	-244.7%	-267.3%	-144.1%	-237.5%	-209.9%	-209.4%	-162.8%	-531.3%
Depreciation & Amortization	1.85M	548K	545K	382K	376K	370K	384K	766K	196K
EPS Basic	-2.27	-0.63	-0.71	-0.50	-0.43	-0.52	-0.40	-0.46	-0.77
EPS Diluted	-2.27	-0.63	-0.71	-0.50	-0.43	-0.52	-0.40	-0.46	-0.77
Weighted Average Basic Shares	57.84M	57.84M	45.82M	41.73M	44.95M	29.77M	35.94M	33.34M	31.04M
Weighted Average Diluted Shares	57.84M	57.84M	45.82M	41.73M	44.95M	29.77M	35.94M	33.34M	31.04M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	35.26M	22.47M	22.39M	16.39M	13.68M	4.95M	21.30M	18.91M
Cost of Goods Sold	19.49M	21.94M	19.30M	13.66M	14.49M	22.32M	40.75M	27.06M
Gross Profit	15.76M	533K	3.09M	2.73M	-811K	-17.37M	-19.45M	-8.15M
Gross Profit Margin	44.7%	2.4%	13.8%	16.6%	-5.9%	-350.9%	-91.3%	-43.1%
Total Operating Expenses	84.10M	75.38M	78.69M	71.35M	56.37M	61.76M	111.21M	79.43M
Research & Development	31.59M	41.14M	48.75M	39.72M	27.22M	20.41M	38.43M	31.86M
Selling, General & Administrative	52.51M	34.23M	29.94M	31.63M	29.15M	41.35M	72.78M	47.57M
Operating Income (EBIT)	-68.34M	-74.84M	-75.60M	-68.63M	-57.18M	-79.13M	-130.66M	-87.58M
Operating Margin	-193.8%	-333.0%	-337.7%	-418.7%	-418.1%	-1598.9%	-613.4%	-463.1%
Income Before Tax (EBT)	-69.11M	-78.62M	-60.39M	142.12M	-302.47M	-175.17M	-115.55M	-93.97M
Interest Income	4.20M	4.50M	5.36M	1.82M	243K	175K	1.93M	2.00M
Interest Expense	4.95M	8.44M	11.11M	18.70M	16.72M	16.17M	15.14M	8.28M
Other Income/Expense	-776K	-3.77M	15.21M	210.75M	-245.29M	-96.04M	15.11M	-6.39M
Net Income	-69.11M	-78.62M	-60.39M	142.12M	-302.47M	-175.17M	-115.55M	-93.97M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	-196.0%	-349.8%	-269.7%	867.2%	-2211.9%	-3539.5%	-542.5%	-496.9%
EBITDA	-66.83M	-73.37M	-74.33M	-67.64M	-55.94M	-77.99M	-129.66M	-87.31M
EBITDA Margin	-189.5%	-326.5%	-332.0%	-412.7%	-409.1%	-1575.9%	-608.7%	-461.6%
Depreciation & Amortization	1.51M	1.48M	1.28M	985K	1.24M	1.14M	1.00M	270K
EPS Basic	-1.66	-2.50	-2.20	6.07	-14.40	-15.40	-12.20	-12.00
EPS Diluted	-1.66	-2.50	-2.20	N/A	-14.40	-15.40	-12.20	-12.00
Weighted Average Basic Shares	41.73M	31.49M	28.40M	23.40M	21.12M	11.40M	9.44M	7.87M
Weighted Average Diluted Shares	41.73M	31.49M	28.40M	30.91M	21.12M	11.40M	9.44M	7.87M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.